MapKure, LLC

2 clinical trials · Sponsor

Record	Firm	Date
A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers (NCT06194877)	MapKure, LLC	2024-04-18
Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors (NCT04249843)	MapKure, LLC	2020-02-17

Every clearance here is in the API, with alerts when new ones post.